WHI-P154 is primarily used in biomedical research as a selective inhibitor of the Janus kinase 3 (JAK3) signaling pathway. It is employed to study the role of JAK3 in immune cell activation and proliferation, particularly in T cells and natural killer cells. Due to its specificity, it helps researchers dissect signaling mechanisms involved in immune responses and inflammation. WHI-P154 has also been utilized in cancer research, especially in exploring the dependency of certain leukemias and lymphomas on JAK-STAT signaling. Its application supports the development of targeted therapies for autoimmune diseases and hematological malignancies.